Across TCGA pan-cancer cohorts, WWTR1 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated WWTR1 data layer compared with 22 for mass-spec protein and 6 for mutation status.
The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher WWTR1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated WWTR1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LUAD show a favorable association.
PDAC, LSCC, and HNSC are the cancer types where WWTR1 mass-spec protein most reproducibly stratifies survival.